跳至主要内容
临床试验/CTRI/2019/05/019284
CTRI/2019/05/019284尚未招募4 期

To compare the safety & efficacy of Sacubitril and Valsartan vs Telmisartan monotherapy in patients of CHF with reduced ejection fraction - COSAVATEL-HF

Dr Kunwar Shailen Dev Singh Guleria0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • 1. Patient of CHF with decreased ejection fraction
  • 2. Adult patients of either sex, consenting for study
  • 3. If no HF hospitalizations in prior year: BNP greater than or equal to 150 pg/mL
  • 4. If a HF hospitalization in prior year: BNP greater than or equal to 100 pg/m

排除标准

  • 1. Unwilling patient.
  • 2. Pregnant females.
  • 3. Estimated glomerular filteration rate less than 30ml/min/1.73m2
  • 4. Serum potassium greater than 5.2mmol/L
  • 5. Symptomatic hypotensive patients
  • 6. SBP less than 100mmHg at screening or less than 95mmHg at randomization
  • 7.Patient with known history of angioedema
  • 8. Patient on drugs that might interact with ARNI/ARBs
  • 9. Patient with structural (valvular) heart disease.
  • 10.Unacceptable side effects with ACE-inhibitors or ARBs

研究者

发起方
Dr Kunwar Shailen Dev Singh Guleria

相似试验